Impaired polyamine metabolism causes behavioral and neuroanatomical defects in a mouse model of Snyder–Robinson syndrome
Year: 2024
Type: article
Abstract: ABSTRACT Snyder–Robinson syndrome (SRS) is a rare X-linked recessive disorder caused by a mutation in the SMS gene, which encodes spermine synthase, and aberrant polyamine metabolism. SRS is characterized by intellectual disability, thin habitus, seizure, low muscle tone/hypotonia and osteoporosis. Progress towards understanding and treating SRS requires a model that recapitulates human gene variants and disease presentations. Here, we evaluated molecular and neurological presentations in the G56S mouse model, which carries a missense mutation in the Sms gene. The lack of SMS protein in the G56S mice resulted in increased spermidine/spermine ratio, failure to thrive, short stature and reduced bone density. They showed impaired learning capacity, increased anxiety, reduced mobility and heightened fear responses, accompanied by reduced total and regional brain volumes. Furthermore, impaired mitochondrial oxidative phosphorylation was evident in G56S cerebral cortex, G56S fibroblasts and Sms-null hippocampal cells, indicating that SMS may serve as a future therapeutic target. Collectively, our study establishes the suitability of the G56S mice as a preclinical model for SRS and provides a set of molecular and functional outcome measures that can be used to evaluate therapeutic interventions for SRS.
Source: Disease Models & Mechanisms
DOI: 10.1242/dmm.050639
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,750
Funders: Richard King Mellon Foundation, University of Pennsylvania, Children's Trust, University of Pittsburgh, Chan Zuckerberg Initiative, National Institutes of Health, Center for Research Computing, University of Pittsburgh, National Cancer Institute, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Children's Hospital of Pittsburgh, Orphan Disease Center, Perelman School of Medicine, University of Pennsylvania
Awards: G2737622950, G2815032092, Implications of Genetic Diversity in Muscular Dystrophy, Self-immolative prodrug/miRNA nanoparticle combinations for cancer treatment, G4566554938, High-Throughput Computing for Genomics and Bioinformatics Research, G5520316217, G642779400, Therapeutic genetics and disease modeling in LAMA2-CMD, Leveraging modulation of polyamine metabolism for therapeutic advantage in genetic disorders
OpenAlex ID: W4392650297
